{"name":"Andrew J. Armstrong, MD","slug":"andrew-j-armstrong-md","ticker":"","exchange":"","domain":"","description":"Andrew J. Armstrong, MD is a clinical researcher and physician focused on developing novel therapies for cancer, particularly in the field of oncology. The company is currently advancing two drug candidates, both in Phase 1 trials, aimed at addressing significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOX3d3Q2pwTDQ3SUJWX3dJZjZ1MU9uVHNTc2JLZEJzQVU0NUcyLW1uVlpXSzRfRVppWmUteHR4RzZWQ1BDdHFEa3lsaUN1eTV3dWxYdHBmQW9ZbEFPSDRhQ1VYLXpwdTlZQWpXZVNWQVl3UE1CT3JydUFPbU9xcFBrZWlCMlRBMXJaN2hsd0dYM1lreXRXSGYwZk9n?oc=5","date":"2026-04-08","type":"pipeline","source":"Medscape","summary":"PSA Often Unchanged With Enzalutamide Progression - Medscape","headline":"PSA Often Unchanged With Enzalutamide Progression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOd3RoRDEwVFBZdG5ZYjZOWFFFZlR6ODFHeVhrdGd0b3BSM0FsNTBweFp4cVNGV2RDejZHUUN0dFozM0xZMzNDT1pjWWxkYS1fdVRMUUFENVJ1M2toUzBPeTF1QnNnOWtHaFBTR2J3anRhZ2o0blF0aWU2LWh0b3VucHBvSy1ja2xtUEtLdmFoV2hoSy04YUhKTF91X3hweWRV?oc=5","date":"2026-02-23","type":"pipeline","source":"ASCO Daily News","summary":"Prostate Cancer Working Group 4: What Does Its Work Mean for the Busy Clinician? - ASCO Daily News","headline":"Prostate Cancer Working Group 4: What Does Its Work Mean for the Busy Clinician?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQOGpSTHZCNDJPZVFfQmg4aHpSVm0weTdWYUVMblB4bkpNMkpWNkdlSnhuSWtGWkpUUzZLdmhvQktaT3pJWE9zTGZlZmRxX2paZ0YzOWxER2Nwb3ZFUEdfaFZIOVlQQllnN1hpLUFxcUd2Q3VsUnZncldHZ2xONXVWeE56YlVUc2c?oc=5","date":"2025-08-11","type":"pipeline","source":"Targeted Oncology","summary":"ARPI Choices Beyond Efficacy in Prostate Cancer - Targeted Oncology","headline":"ARPI Choices Beyond Efficacy in Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNMFpOWGV2RlYxclUzSlJXcnprSHM2ejk5SlZYRmMzRktHd0k1R2NPOUdXOG1iZHFsemJWUVdOeXVybUY1ODhCa2NPd2hFajJHSXdDWEc5NUp2SU1CYjNSMmdGejY3eEE3bk9tS0RCdjcwNVplRHhubzJLX3RvTzBpQzVQYmlRcW5tTWFuSGI4Zi16Wk0tWUViVkptVElWclhjNHc?oc=5","date":"2025-08-02","type":"pipeline","source":"peoplespharmacy.com","summary":"Show 1439: What Men Need to Know to Overcome Prostate Cancer - peoplespharmacy.com","headline":"Show 1439: What Men Need to Know to Overcome Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9zalJtSW5LdmprSUdfRzg3MkhJLTk5Wm8tQm91YW9TMUlSR294eDh2V01yRU93NVl1WWYtWFdKYXRWSUJVWFAzcWg3MV9pTVRnalRQSXZzZUZIUUtWbTRYYmxzUmxZUE1Pczd1RmFiTGV4enM0eWdTbVdIOA?oc=5","date":"2024-09-06","type":"pipeline","source":"Renal and Urology News","summary":"Prostate Cancer Treatment Challenge: Which Drugs to Use First - Renal and Urology News","headline":"Prostate Cancer Treatment Challenge: Which Drugs to Use First","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPN1hieko2eTJuYmpEUTZKWC1IVC1aWmQ0T3BWYnI0bUpHRzJ6OFQ1d3ZHV3owbnFja3hxbFdTcW9LU2QzaWUxZFViWTAyWDRxQjFSSkZ4REVhYlgzN2NKSUFwWmdadUNwNDlxUWdnbmc5SVhYektRQWRfYVdXSW56aG10cVNON2kydF8xX01VdmpDTHdmb2t2bzVnY0V1M01OU3ZnSVJ1NzF1RmM?oc=5","date":"2023-06-01","type":"pipeline","source":"Duke Health","summary":"AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer - Duke Health","headline":"AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZWZZNzNaMFg1cGM2aXp5VDc5djQ1MVF2N01vdXFfREgyczFZTjdZdGM0QmFhNzZUYTNOdVdaOTlLT3FFTzhXN1hFMU0xLWFhUS1mR1RLcGVscDVtRFEzUnBKY24yM1N5VjB4Vl9XV2EtdTF1V2N0ZXcxaEwtbGM5bDVsblRSTnVMVkk4aGFTSXhkNTRBOEQ5R1JEbkNIT0N2LTlHYzVGV282bzRtamRydUxZb0dzeWJDUXZnek1iV211dDA?oc=5","date":"2022-10-05","type":"pipeline","source":"OncLive","summary":"Novel AR-Targeted Therapies for Metastatic Hormone-Sensitive Prostate Cancer: Which One to Choose - OncLive","headline":"Novel AR-Targeted Therapies for Metastatic Hormone-Sensitive Prostate Cancer: Which One to Choose","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOdXJ6M29sMERnQlBid0RHSlhFRERuamxFbnJWV2RJSFFBQ2tmckFwcjB5RTYwZ25yZkVLOXE1dnRlZXAwczN2d2t0b25KVFE3OTB4T1J5djVBSlRoVDZBNlE5SWl4S3BRYlJVX3VHR0c4cVJWR2o5VXk2eGFfdmx4N3M1RGM4UmhWOFctd1NqRVo5RFUzZjA4TWw0Q2ExY0lSd3lUbXJQRmZKWUR5Vl80UHEwbEgtOUFVNjZIdll1R3J4YUFPNHA3RUFVa3Y0UTgtR19lMVRkbUNXQkZ5SmlDamFHbndnLU93OVE?oc=5","date":"2022-08-04","type":"pipeline","source":"CancerNetwork","summary":"Andrew J. Armstrong, MD, Details PSMA-PET Scan Parameters Indicating Better Survival Outcomes With 177Lu-PSMA-617 in mCRPC - CancerNetwork","headline":"Andrew J. Armstrong, MD, Details PSMA-PET Scan Parameters Indicating Better Survival Outcomes With 177Lu-PSMA-617 in mCR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQNDR3ZTl6Wks5RFRwYnVyYmRuM3lNZmM1TUNya0pTR3FzZlBveEJaaGRqN25FQjVieHhiMjVxMHhsUzlZRlh0WHJQSHZMU25KTFZ1RnR5aldBWU9EenltX09iTVBUeTAzUnFtZXVzVHhQcFRBaTVScEdJcTZiVzBhUk9LRXRBYkFNVlBlak91QUlmNURCam44Z203TWt2M3dKYnlMZ2QtS3ExMDlIdWx2QXpsNlVCbE1G?oc=5","date":"2022-06-05","type":"pipeline","source":"Urology Times","summary":"PSMA-PET criteria identified to optimize mCRPC patient selection for 177Lu-PSMA-617 - Urology Times","headline":"PSMA-PET criteria identified to optimize mCRPC patient selection for 177Lu-PSMA-617","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQWWV1dVloWURzdXZDZlcyRkh6emZnUXNyQi1RWGhIdHNQRGRPVkczbV9lVkxSQ2hLX1VGcnducl91akZ4V0NtNWtTeUFyR0Jnb0pKdDhuVTZZakozZmFFVWVWckhpSHQ4dXVqMnRqcHNWNDhXbm9KaVU0QnpIOHFLcFJFcXRfR0p5TFJhSHFMUXd3dHo2TURqRVdpMnNXYzV2R1Q4MlE3ZmFJd1pMcW9QMnhhRnBrbkVjTU1yaWIxbGU?oc=5","date":"2021-12-07","type":"pipeline","source":"Urology Times","summary":"Dr. Armstrong on the efficacy of AR inhibitors in men with oligometastatic prostate cancer - Urology Times","headline":"Dr. Armstrong on the efficacy of AR inhibitors in men with oligometastatic prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbUw4QUZ6TzhtbGpEcC1UOThCbk80c2lSMHM2VVNVbEVqNml6SHI5TUEwS1N3RmMwbkpwSk9LZEJCdDBsZkR2QndaWFA0NHhEU1E5SU0tckt0TVFGSlJVYjFyTjlZUEtKeHlrUjJ0ekpidXdYcU1xMDZKWnNHSjhoVUpfcnJ5YXFTYWY4UEhmQXc4V2NjSElkVFRQRUpjOXM1VV9kQnFiZ0dJSjFCU1lremp1UGJKcTha?oc=5","date":"2019-09-10","type":"pipeline","source":"The ASCO Post","summary":"Many Choices Now for Men With Metastatic Hormone-Sensitive Prostate Cancer: How to Decide? - The ASCO Post","headline":"Many Choices Now for Men With Metastatic Hormone-Sensitive Prostate Cancer: How to Decide?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE0tc1RNcXozZHczUEF0emhfbXB6ZGxPYUk3bXJ2N1dWeXFLaE1kbkFxNnZKLThQcXVXX1I0Y1UxOGlfanlGVmhScmJjWWdOd0NCMUdEVEFiWVA2SFJadXhHUQ?oc=5","date":"2014-06-01","type":"pipeline","source":"NEJM","summary":"Enzalutamide in Metastatic Prostate Cancer before Chemotherapy - NEJM","headline":"Enzalutamide in Metastatic Prostate Cancer before Chemotherapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}